Wird geladen...
Discovery of new biomarkers for malignant mesothelioma
Malignant mesothelioma is an asbestos-induced, aggressive tumour with limited treatment options and very poor outcome. Currently, there are no tumour biomarkers in widespread clinical use for this disease. Soluble mesothelin is the most intensively investigated mesothelioma biomarker and has been ap...
Gespeichert in:
| Veröffentlicht in: | Curr Pulmonol Rep |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Springer US
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4356891/ https://ncbi.nlm.nih.gov/pubmed/25927434 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13665-015-0106-8 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|